BULLFROG AI HOLDINGS, INC. Stock Issued During Period, Value, Conversion of Convertible Securities
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- BULLFROG AI HOLDINGS, INC. stock issued during period, value, conversion of convertible securities for the quarter ending 2023-03-31 was $1.54M.
- BULLFROG AI HOLDINGS, INC. stock issued during period, value, conversion of convertible securities for the quarter ending 2022-06-30 was $226.14K.
- BULLFROG AI HOLDINGS, INC. stock issued during period, value, conversion of convertible securities for fiscal 2023 was $1.54M, a 579.06% increase from fiscal 2022.
- BULLFROG AI HOLDINGS, INC. stock issued during period, value, conversion of convertible securities for fiscal 2022 was $226.14K.
| Period end | Stock Issued During Period, Value, Conversion of Convertible Securities 3 month | Stock Issued During Period, Value, Conversion of Convertible Securities 12 month |
|---|---|---|
| 2023-12-31 | $1.54M 10-K · filed 2025-03-14 | |
| 2023-03-31 | $1.54M 10-Q · filed 2024-11-08 | |
| 2022-12-31 | $226.14K 10-K · filed 2024-03-29 | |
| 2022-06-30 | $226.14K 10-Q · filed 2023-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B |